Pages that link to "Item:Q2632060"
From MaRDI portal
The following pages link to Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide (Q2632060):
Displaying 12 items.
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients (Q536537) (← links)
- Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV (Q1661641) (← links)
- Modeling of fusion inhibitor treatment of RSV in African green monkeys (Q1714364) (← links)
- Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor (Q1788684) (← links)
- Effect of DAA therapy in hepatitis C treatment -- an impulsive control approach (Q1981065) (← links)
- A model for SARS-CoV-2 infection with treatment (Q2223099) (← links)
- A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (\(\mathrm{TNF}-\alpha\) inhibitor) therapy (Q2419861) (← links)
- Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects (Q2440890) (← links)
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach (Q2657593) (← links)
- Analysis of HIV latent infection model with multiple infection stages and different drug classes (Q5052707) (← links)
- Viral dynamics of an HIV model with pulse antiretroviral therapy and adherence (Q5225391) (← links)
- Mathematical modelling of HIV-1 transcription inhibition: a comparative study between optimal control and impulsive approach (Q6060718) (← links)
